United Kingdom cancer
diagnostics market is anticipated to witness a robust CAGR in the forecast
period, 2023-2027. The market is driven by the surge in occurrence and
prevalence of cancer and the technological advancements in cancer diagnostic
technology. Supportive government initiatives and the strong healthcare
infrastructure of the country are further expected to fuel the United Kingdom
cancer diagnostics market growth over the next five years.
Increased Prevalence of
Cancer Drives the Market Growth
Cancer is a condition in
which cells in a particular part of the body grow uncontrollably. The cancerous
cell can enter and destroy surrounding tissue, including organs. It generally
originates in one part of the part
before spreading into the whole body and the process is known as metastasis.
According to a study by National Health Service, one in two will develop some
kind of cancer in their entire lifetime, which shows it is highly prevalent
across the country. The four most common types of cancer occurring in the
United Kingdom are lung cancer, prostate cancer, bowel cancer, and breast
cancer. Growing health-consciousness among people is making them opt for
regular health check-ups. Cancer diagnostics laboratories witness a large
number of patients who come to check if there is any presence of cancerous
cells in the body as a preventive measure. Also, the rise in the disposable
income of middle-class families is improving the quality of healthcare services
they are able to afford and is expected to boost the demand for cancer
diagnostics services in the country over the next five years.
Favorable Government Policies
Fuels the Market Growth
The government of the United
Kingdom has set a 10-year cancer plan for England. The NHS long term plan was
made and published in 2019, and at that time, the cancer survival rate was the
highest in the previous years. National Health Service (NHS) is taking every
possible measure to improve cancer survival, and cancer diagnosis is a priority
for the government. Patients diagnosed with early stages of cancer that are at
stage 1 and stage 2 have the best chance for survival. The long-term plan has
set a target that by 2028, the number of cancers diagnosed at stage 1 and stage
2 will grow from half to three-quarters of cancer, which means that 55,000
patients will survive cancer for at least five years after diagnosis. The plan
is expected to improve the patient experience outcome and quality of life of
patients. It is expected to lower the variation and inequalities in cancer
treatment. Therefore, the announcement of initiatives and plans by the government
to lower the mortality rate of cancer and enhance the chances of survival from
cancer is expected to fuel the growth of the United Kingdom cancer diagnostics
market in the next five years.
Booming Healthcare
Infrastructure Supports the Market Growth
The permanent residents of
the United Kingdom are entitled to free healthcare services through the
National Healthcare Service. Also, the patients can avail of private health
insurance services to have quicker access to better facilities, less waiting time,
and skilled healthcare professionals. Each region of the United Kingdom has its
own National Healthcare Service body, and the Department of Health oversees it.
National Healthcare Service provides a number of services to women residents.
They can be accessed through well woman clinics as they offer services for
screening for cervical and breast cancer. The supportive healthcare system and
the rise in the number of patients availing of public facilities are expected
to propel the United Kingdom cancer diagnostics market over the forecast
period.
Click here to download the sample
Market Segmentation
The United Kingdom cancer
diagnostics market is segmented into product, technology, application,
end user,
regional distribution, and competitive landscape. Based on product, the
market is bifurcated into consumables and instruments. Based on technology, the
market is divided into IVD testing, imaging, and biopsy. Based on application,
the market is divided into breast cancer, lung cancer, colorectal cancer, and others.
Based on end user, the market is divided into hospitals & clinics,
diagnostic laboratories, and others. The United Kingdom cancer
diagnostics market is studied in major regions namely London, Southeast, East
Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, and rest
of United Kingdom.
Market Players
GE Healthcare UK Limited,
Becton, Dickinson U.K. Limited, Roche Diagnostics UK, Abbott Laboratories
Limited, Fujifilm Healthcare UK Limited, Hologic (UK) Limited, Agilent Technologies
UK Limited, are the major market players operating in the United Kingdom cancer
diagnostics market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 – 2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023 – 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
·
Product
·
Technology
·
Application
·
End User
|
|
Regional scope
|
London, Southeast, East Anglia, Scotland, Southwest, East
Midlands, Yorkshire & Humberside, Rest of United Kingdom
|
|
Key companies profiled
|
GE Healthcare UK Limited, Becton,
Dickinson U.K. Limited, Roche Diagnostics UK, Abbott Laboratories Limited, Fujifilm
Healthcare UK Limited, Hologic (UK) Limited, Agilent Technologies UK Limited
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, United Kingdom cancer
diagnostics market has been segmented into following categories, in addition to
the industry trends which have also been detailed below:
·
United Kingdom Cancer Diagnostics
Market, By Product:
- United Kingdom Cancer Diagnostics Market, By Technology:
- IVD Testing
- Imaging
- Biopsy
- United Kingdom Cancer Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Others
- United Kingdom Cancer Diagnostics Market, By End
User:
- Hospitals
& Clinics
- Diagnostic
Laboratories
- Others
- United Kingdom Cancer
Diagnostics Market, By Region:
o London
o Southeast
o East Anglia
o Scotland
o Southwest
o East Midlands
o Yorkshire & Humberside
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in United Kingdom cancer diagnostics
market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to
five).
United Kingdom cancer diagnostics
market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]